Protalix BioTherapeutics
PLX
#8281
Rank
NZ$0.38 B
Marketcap
NZ$4.76
Share price
-3.40%
Change (1 day)
20.34%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): NZ$12.95 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$61.84 Million. In 2024 the company made an earning of NZ$8.89 Million a decrease over its 2023 earnings that were of NZ$20.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$12.95 M45.63%
2024 NZ$8.89 M-55.62%
2023 NZ$20.04 M-199.05%
2022 -NZ$20.25 Million-40.38%
2021 -NZ$33.95 Million-732.31%
2020 NZ$5.36 M-130.53%
2019 -NZ$17.59 Million189.85%
2018 -NZ$6.07 Million-95.29%
2017 -NZ$0.13 Billion308.12%
2016 -NZ$31.58 Million-32.37%
2015 -NZ$46.69 Million10.11%
2014 -NZ$42.4 Million-7.59%
2013 -NZ$45.88 Million
2011 -NZ$53.13 Million-19.39%
2010 -NZ$65.91 Million20.87%
2009 -NZ$54.53 Million32.26%
2008 -NZ$41.23 Million-5.46%
2007 -NZ$43.61 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.66 Million1.03%
2000 -NZ$0.66 Million-53.22%
1999 -NZ$1.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$20.21 B 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$0.99 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$8.49 M-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.67 B 28,751.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel